Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Tofacitinib helped regrow hair in a woman with alopecia areata.

JAK inhibitors are effective for long-term management of alopecia areata.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

People with weakened immune systems, like those with SLE, are at higher risk for TB.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

The man's skin condition improved with sun protection and topical steroids, but UV exposure still caused flare-ups.

Tofacitinib treatment is used for teenagers with alopecia areata.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Most children with childhood-onset lupus in Baghdad responded well to treatment, but some developed chronic kidney disease or died.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Denosumab may cause alopecia areata.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.